Notice of Half Year ResultsSource: RNS
31 August 2022
BIOPHARMA CREDIT PLC
NOTICE OF HALF YEAR RESULTS
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, will announce its Half Year Results for the period ending 30 June 2022 on Wednesday, 14 September 2022.
A management presentation will be delivered at 14.00 BST through a webcast facility. To register to attend or request details, RSVP to email@example.com.
BioPharma Credit PLC
via Link Company Matters Limited
+44 (0) 1392 477 500
+44 (0)20 7466 5000
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.